Used as a key intermediate in pharmaceutical synthesis, particularly in Suzuki-Miyaura cross-coupling reactions to form carbon-carbon bonds. Its boronic ester group enables efficient coupling with aryl or heteroaryl halides, making it valuable in the development of active pharmaceutical ingredients (APIs). The fluorine and methyl substituents enhance reactivity and influence electronic properties, aiding in the optimization of drug candidates targeting CNS disorders, inflammation, and oncology. Commonly employed in medicinal chemistry for library synthesis and structure-activity relationship (SAR) studies due to its stability and selective reactivity.